{"celex_id": "31993R1959", "uri": "http://publications.europa.eu/resource/cellar/c4c25b54-a01a-41f4-92bc-c3bdbee4d50f", "type": "Regulation", "concepts": ["2069", "2773", "2775", "3815", "4381"], "title": "Commission Regulation (EEC) No 1959/93 of 19 July 1993 amending Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff and Commission Regulation (EEC) No 3565/88 concerning the classification of certain goods in the combined nomenclature\n", "header": "21.7.1993 EN Official Journal of the European Communities L 177/12\nCOMMISSION REGULATION (EEC) No 1959/93\nof 19 July 1993\namending Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff and Commission Regulation (EEC) No 3565/88 concerning the classification of certain goods in the combined nomenclature\nTHE COMMISSION OF THE EUROPEAN COMMUNITIES", "recitals": ",\nHaving regard to the Treaty establishing the European Economic Community,\nHaving regard to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff\u00a0(1), as last amended by Regulation (EEC) No 1667/93\u00a0(2), and in particular Article 9 thereof,\nWhereas Regulation (EEC) No 2658/87 established the nomenclature of goods, hereinafter referred to as the combined nomenclature, which serves the purposes both of the Community's Common Customs Tariff and of its external trade statistics;\nWhereas in order to ensure uniform application of the combined nomenclature, it is necessary to adopt provisions concerning the classification of halogenated derivatives of adrenal cortical hormones of CN code 2937\u00a022\u00a000; whereas an additional note to this effect should be inserted in Chapter 29 of the combined nomenclature; whereas Regulation (EEC) No 2658/87 should be amended accordingly;\nWhereas the present Regulation is relevant to the product \u2018mometazone furoate (INNM)\u2019, listed as the second product in the Annex to Commission Regulation (EEC) No 3565/88\u00a0(3); whereas, in consequence, the latter Regulation should be amended accordingly;\nWhereas the provisions of this Regulation are in accordance with the opinion of the Nomenclature Committee,", "main_body": ["The following additional note is introduced in Chapter 29 of the combined nomenclature annexed to Regulation (EEC) No 2658/87:\n\u2018Additional note\n1. For the purposes of subheading 2937\u00a022\u00a000, the expression \u201cadrenal cortical hormones\u201d means natural adrenal cortical hormones, or those reproduced by synthesis, and their derivatives, provided that the latter certain hormone-activity.\u2019", "In the table annexed to Regulation (EEC) No 3565/88, the entry relating to item 2 (\u2018mometazone furoate (INNM)\u2019) shall be deleted.", "This Regulation shall enter into force on the 21st day following its publication in the Official Journal of the European Communities.\nThis Regulation shall be binding in its entirety and directly applicable in all Member States."], "attachments": "Done at Brussels, 19 July 1993.\nFor the Commission\nChristiane SCRIVENER\nMember of the Commission\n(1)\u00a0\u00a0OJ No L 256, 7. 9. 1987, p. 1.\n(2)\u00a0\u00a0OJ No L 158, 30. 6. 1993, p. 25.\n(3)\u00a0\u00a0OJ No L 311, 17. 11. 1988, p. 25."}